Key Findings from GAO Report on Orphan Drug Approval Modernization
In November 2018, the Government Accountability Office (GAO) released a report titled “FDA Could Improve Designation Review Consistency; Rare Disease […]
Key Findings from GAO Report on Orphan Drug Approval Modernization Read Post »